Stock Price Quote

SARVODAYA LABS LTD.

NSE : NABSE : 530501ISIN CODE : INE153B01017Industry : Pharmaceuticals & DrugsHouse : Private
BSE0.000 (0 %)
PREV CLOSE ( ) NA
OPEN PRICE ( ) 0.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )0.00 0.00
52 WK LOW / HIGH ( ) 00
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1990
Management Info
- Chairman - Managing Director
Registered Office

Address 32/B, Sidhapura Industrial Estate, S V Road Goregaon (W),
Mumbai,
Maharashtra-400064

Phone 022- 28726192 28729263 28754305

Email --

Website NA

Registrars Details
Sarvodaya Labs Ltd.
32/B, Sidhapura Industrial Estate, S V Road Goregaon (W),Mumbai
Listing : BSE

NEWS

No News Found

Financials

in Millions
QTR Mar 01 ANNUAL
Net Profit
Gross Profit
Operating Profit
Net Sales

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE)
peergroup  28027.55 (1.02%)
M.Cap ( in Cr)59735.93
Astrazeneca Pharma I (BSE)
peergroup  6715.20 (2.33%)
M.Cap ( in Cr)16805.00
Neuland Laboratories (BSE)
peergroup  16830.05 (0.83%)
M.Cap ( in Cr)21412.96
AMI Organics (BSE)
peergroup  2269.45 (5.86%)
M.Cap ( in Cr)9292.12
Innova Captab (BSE)
peergroup  1135.00 (11.05%)
M.Cap ( in Cr)6472.14

Shareholding Pattern

No Data Found

About

no data found

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.